Physician profile
Trung Phan
NPI 1912389016
$2,517.73
in general payments reported to CMS, 2019-2025
8 companies · $1,477 in 2025
The $1,477 reported for 2025 was more than what 97% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.93 · 2020: $200 · 2021: $11.87 · 2022: $374 · 2023: $220 · 2024: $197 · 2025: $1,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $964 · Food and Beverage: $742 · Gift: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $963.72 |
| Food and Beverage | $741.61 |
| Gift | $189.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Henry Schein, INC. | $989.53 | 2024-2025 | Adec INC Newtron Slim 61 Kit, Edgetaper Platinum |
| Patterson Companies, INC. | $525.94 | 2022-2025 | |
| A-Dec, INC. | $389.00 | 2020-2023 | |
| Align Technology, INC. | $372.40 | 2024-2025 | Invisalign |
| Orapharma, A Division of Bausch Health US, LLC | $97.39 | 2019-2024 | Ossix Plus, Arestin |
| Straumann USA LLC | $59.10 | 2022 | |
| Gc America INC. | $57.57 | 2025 | G-Aenial, Everstick |
| Dentsply Sirona INC | $26.80 | 2021-2023 | Cavitron |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trung Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.